Suppr超能文献

人红细胞中90 kDa膜结合型多催化蛋白酶内源性抑制剂的鉴定与纯化

Identification and purification of a 90-kDa membrane-bound endogenous inhibitor of multicatalytic proteinase from human erythrocytes.

作者信息

Khan M T, Wang K, Roufogalis B D

机构信息

Department of Pharmacy, University of Sydney, NSW, Australia.

出版信息

Biochem Biophys Res Commun. 1995 Sep 25;214(3):957-62. doi: 10.1006/bbrc.1995.2379.

Abstract

We have identified and purified an endogenous inhibitor of multicatalytic proteinase (MCP) from human erythrocyte membranes. The inhibitor showed a molecular mass of 90 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The inhibitor protein was purified from the erythrocyte membranes using Heparinagarose and hydroxylapatite chromatography and the size exclusion on a Biogel A 1.5 m column in the presence of high salt. The 90-kDa protein inhibited all three peptidase activities of MCP; trypsin-like, chymotrypsin-like and peptidyl glutamyl peptide hydrolyzing (PGPH). However, it failed to cause any significant inhibition of caseinolytic activity of MCP, suggesting that the regulation of proteinase and peptidase activities is distinct. The inhibition of the chymotrypsin-like activity was noncompetitive. The results suggest that the 90-kDa inhibitor protein may be an important regulator of membrane-bound MCP.

摘要

我们已经从人红细胞膜中鉴定并纯化出一种多催化蛋白酶(MCP)的内源性抑制剂。在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上,该抑制剂显示分子量为90 kDa。通过肝素琼脂糖和羟基磷灰石层析以及在高盐存在下在Biogel A 1.5 m柱上进行尺寸排阻,从红细胞膜中纯化出抑制剂蛋白。这种90 kDa的蛋白抑制了MCP的所有三种肽酶活性;胰蛋白酶样、胰凝乳蛋白酶样和肽基谷氨酰肽水解(PGPH)活性。然而,它对MCP的酪蛋白水解活性没有引起任何显著抑制,这表明蛋白酶和肽酶活性的调节是不同的。对胰凝乳蛋白酶样活性的抑制是非竞争性的。结果表明,90 kDa的抑制剂蛋白可能是膜结合MCP的重要调节因子。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验